Pfizer and BioNTech to start human trials of COVID-19 vaccine
Following regulatory approval, the first clinical trial of the coronavirus vaccine candidates is said to commence in late April
Following regulatory approval, the first clinical trial of the coronavirus vaccine candidates is said to commence in late April
Cell based kit including assay ready Hep-G2 cells to measure drug induced phospholipidosis (DIPL)
Swift Biosciences and SeraCare Partner on Circulating Tumor DNA Standards for NGS-Based Oncology Assays
The next generation CESI-MS system extends capabilities for biopharmaceutical, proteomics and metabolomics researchers
New NGS products for streamlined sample prep and ovarian cancer research
Large-scale study demonstrates metal contaminants in food and water are associated with coronary heart disease and cardiovascular disease
Increased Productivity in Pesticide Residue Analysis – Quantifying 440 Pesticides Following China GB 2763-2014